Relative perioperative bradycardia does not lead to adverse outcomes after cardiac transplantation

Daniel R Goldstein; Christopher S Coffey; Raymond L Benza; Navin C Nanda; Robert C Bourge

doi:10.1034/j.1600-6143.2003.00073.x

Back

Relative perioperative bradycardia does not lead to adverse outcomes after cardiac transplantation

Journal article

Open access

Peer reviewed

Relative perioperative bradycardia does not lead to adverse outcomes after cardiac transplantation

Daniel R Goldstein, Christopher S Coffey, Raymond L Benza, Navin C Nanda and Robert C Bourge

American journal of transplantation, Vol.3(4), pp.484-491

04/2003

DOI: 10.1034/j.1600-6143.2003.00073.x

PMID: 12694073

Files and links (1)

url

https://doi.org/10.1034/j.1600-6143.2003.00073.xView

Published (Version of record) Open Access

Abstract

Since the effects of bradycardia after cardiac transplantation are not known, we tested the hypothesis that perioperative bradycardia would lead to an increase in adverse outcomes after cardiac transplantation. We conducted a retrospective case control study with inclusion criterion of a heart rate (HR) less than 80 bpm during the 1st week after transplantation. Control patients were matched for gender, age and time since transplantation. We identified 34 patients as having perioperative bradycardia out of the 174 who underwent cardiac transplantation between 1994 and 1997. The results demonstrated no significant differences in donor ischemic times (180 vs. 183, p = 0.88), operative surgeon (p = 0.62) or pretransplant cardiac disease (p = 0.81) between groups. Bradycardic patients were more likely to be on pretransplant amiodarone (RR = 20.4, p < 0.001). Perioperative bradycardia did not lead to increases in cellular rejection (p = 0.72) or vasculopathy (p = 0.79). The patients prescribed pretransplant amiodarone (n = 14) had a trend toward delayed time to first rejection episode (31.0 vs. 15.5 days, median, p = 0.07). In conclusion, perioperative bradycardia does not increase adverse outcomes after cardiac transplantation and is associated with pretransplant use of amiodarone. Amiodarone may modify the recipients' immune response by delaying the occurrence of rejection.

Amiodarone - therapeutic use

Anti-Arrhythmia Agents - therapeutic use

Bradycardia - physiopathology

Case-Control Studies

Heart Transplantation

Humans

Multivariate Analysis

Retrospective Studies

Treatment Outcome

Details

Title: Subtitle: Relative perioperative bradycardia does not lead to adverse outcomes after cardiac transplantation
Creators: Daniel R Goldstein - Department of Internal Medicine, Division of Cardiovascular Medicine, Yale University School of Medicine, 3FM-Cardiology, 333 Cedar St, New Haven CT 06520, USA. daniel.goldstein@yale.edu
Christopher S Coffey
Raymond L Benza
Navin C Nanda
Robert C Bourge
Resource Type: Journal article
Publication Details: American journal of transplantation, Vol.3(4), pp.484-491
DOI: 10.1034/j.1600-6143.2003.00073.x
PMID: 12694073
NLM abbreviation: Am J Transplant
ISSN: 1600-6135
eISSN: 1600-6143
Language: English
Date published: 04/2003
Academic Unit: Biostatistics
Record Identifier: 9984214724202771

Metrics

12 Record Views

12 Times Cited - Web of Science